Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study - Concepedia

Concepedia

Publication | Closed Access

Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study

96

Citations

15

References

2012

Year

Irene Kuter, Julia M.W. Gee, Roberto Hegg, Christian F. Singer, Rajendra Badwe, Elizabeth Lowe, Ugochi Emeribe, Elizabeth J. Anderson, Francisco Sapunar, Pauline Finlay,

Breast Cancer Research and Treatment

Endocrine OncologyNeoadjuvant Endocrine TherapyMedicinePharmacologyClinical TrialsBreast CancerPharmacotherapyDose-dependent ChangeEndocrinologyOncologyRadiation OncologyCancer ResearchEndocrine-related CancerHealth Sciences

References

	Year	Citations

Page 1

Page 1